ChanTest announces drug discovery services using the Enamine 3D compound library

17-Oct-2012 - USA

ChanTest announced the addition of a 50,000 compound chemical library from Enamine Ltd., a provider of screening compounds and chemical building blocks. This compound library (3D Diversity Set) will be available to ChanTest clients effective immediately as a key tool for drug discovery services.

Enamine created this 3D Diversity Set of compounds by selecting from their 1.6 million compound high throughput screening collection (HTS collection) based on the diversity of three dimensional shapes. All compounds in the HTS collection are "drug-like" according to Lipinski Rules, so compounds in the 3D Diversity Set have maximum diversity based on
molecular shape and structural/physiochemical features common to known drugs.

Bill Heilman, Business Development Director, at Enamine, said, "We are excited about partnering with ChanTest. Our company and reputation grows among professional screening companies and academic research centers as more research programs screen our compounds in various assays."

Other news from the department research and development

More news from our other portals

So close that even
molecules turn red...